Your browser doesn't support javascript.
loading
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
Labbé, Catherine; Cabanero, Michael; Korpanty, Grzegorz J; Tomasini, Pascale; Doherty, Mark K; Mascaux, Céline; Jao, Kevin; Pitcher, Bethany; Wang, Rick; Pintilie, Melania; Leighl, Natasha B; Feld, Ronald; Liu, Geoffrey; Bradbury, Penelope Ann; Kamel-Reid, Suzanne; Tsao, Ming-Sound; Shepherd, Frances A.
Afiliación
  • Labbé C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada; Division of Respirology and Thoracic Surgery, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Chemin Ste-Foy, Québec,
  • Cabanero M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Korpanty GJ; Canadian Cancer Trials Group, Queen's University, 10 Stuard Street, Kingston, ON, K7L 3N6, Canada. Electronic address: greg.korpanty@gmail.com.
  • Tomasini P; Aix-Marseille University, Public Assistance, Marseille Hospitals, 80 Rue Brochier, 13005 Marseille, France. Electronic address: pascaletomasini@yahoo.fr.
  • Doherty MK; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: mark.doherty@sunnybrook.ca.
  • Mascaux C; Aix-Marseille University, Public Assistance, Marseille Hospitals, 80 Rue Brochier, 13005 Marseille, France. Electronic address: celinejmmascaux@gmail.com.
  • Jao K; Division of Medical Oncology and Hematology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, Montreal, QC, H4J 1C5, Canada. Electronic address: kevin.jao@mail.mcgill.ca.
  • Pitcher B; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: bethany.r.gill@gmail.com.
  • Wang R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: rick.wang@uhnresearch.ca.
  • Pintilie M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: pintilie@uhnresearch.ca.
  • Leighl NB; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: natasha.leighl@uhn.ca.
  • Feld R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: ronald.feld@uhn.ca.
  • Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: geoffrey.liu@uhn.ca.
  • Bradbury PA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: penelope.bradbury@uhn.ca.
  • Kamel-Reid S; Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Electronic address: suzanne.kamel-reid@uhn.ca.
  • Tsao MS; Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Electronic address: ming.tsao@uhn.ca.
  • Shepherd FA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: frances.shepherd@uhn.ca.
Lung Cancer ; 111: 23-29, 2017 09.
Article en En | MEDLINE | ID: mdl-28838393

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Neoplasias Pulmonares / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Neoplasias Pulmonares / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article